| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1469650
[patent_doc_number] => 06406911
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'Compositions and methods for sensitive detection of HIV infection and monitoring of drug resistance'
[patent_app_type] => B1
[patent_app_number] => 09/314259
[patent_app_country] => US
[patent_app_date] => 1999-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13638
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/406/06406911.pdf
[firstpage_image] =>[orig_patent_app_number] => 09314259
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/314259 | Compositions and methods for sensitive detection of HIV infection and monitoring of drug resistance | May 17, 1999 | Issued |
| 09/313913 | NOVEL IL-9/IL-2 RECEPTOR-LIKE MOLECULES AND USES THEREOF | May 17, 1999 | Abandoned |
Array
(
[id] => 1474119
[patent_doc_number] => 06387670
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => 'Method for producing recombinant virus'
[patent_app_type] => B1
[patent_app_number] => 09/308398
[patent_app_country] => US
[patent_app_date] => 1999-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13112
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/387/06387670.pdf
[firstpage_image] =>[orig_patent_app_number] => 09308398
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/308398 | Method for producing recombinant virus | May 17, 1999 | Issued |
Array
(
[id] => 990915
[patent_doc_number] => 06919442
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-07-19
[patent_title] => 'Nucleic acids comprising a post-transcriptional regulatory element (PRE) and their uses'
[patent_app_type] => utility
[patent_app_number] => 09/673716
[patent_app_country] => US
[patent_app_date] => 1999-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19231
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/919/06919442.pdf
[firstpage_image] =>[orig_patent_app_number] => 09673716
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/673716 | Nucleic acids comprising a post-transcriptional regulatory element (PRE) and their uses | May 17, 1999 | Issued |
Array
(
[id] => 1483792
[patent_doc_number] => 06365150
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'Lentiviral packaging cells'
[patent_app_type] => B1
[patent_app_number] => 09/311684
[patent_app_country] => US
[patent_app_date] => 1999-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9580
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365150.pdf
[firstpage_image] =>[orig_patent_app_number] => 09311684
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/311684 | Lentiviral packaging cells | May 12, 1999 | Issued |
Array
(
[id] => 1445923
[patent_doc_number] => 06368597
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'Methods of treating diabetes'
[patent_app_type] => B1
[patent_app_number] => 09/305989
[patent_app_country] => US
[patent_app_date] => 1999-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 9
[patent_no_of_words] => 11857
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/368/06368597.pdf
[firstpage_image] =>[orig_patent_app_number] => 09305989
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/305989 | Methods of treating diabetes | May 5, 1999 | Issued |
Array
(
[id] => 4344992
[patent_doc_number] => 06290950
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Mycosis vaccines'
[patent_app_type] => 1
[patent_app_number] => 9/269342
[patent_app_country] => US
[patent_app_date] => 1999-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 30827
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/290/06290950.pdf
[firstpage_image] =>[orig_patent_app_number] => 269342
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/269342 | Mycosis vaccines | May 4, 1999 | Issued |
Array
(
[id] => 1495000
[patent_doc_number] => 06342596
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-29
[patent_title] => 'Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress'
[patent_app_type] => B1
[patent_app_number] => 09/304121
[patent_app_country] => US
[patent_app_date] => 1999-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14209
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/342/06342596.pdf
[firstpage_image] =>[orig_patent_app_number] => 09304121
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/304121 | Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress | May 2, 1999 | Issued |
Array
(
[id] => 5999294
[patent_doc_number] => 20020028208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => 'NUCLEIC ACID ENCODING FELINE CD86'
[patent_app_type] => new
[patent_app_number] => 09/303510
[patent_app_country] => US
[patent_app_date] => 1999-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 43439
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028208.pdf
[firstpage_image] =>[orig_patent_app_number] => 09303510
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/303510 | Nucleic acid encoding feline CD86 | Apr 29, 1999 | Issued |
Array
(
[id] => 4328397
[patent_doc_number] => 06312955
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Streptococcus gordonii strains resistant to fluorodeoxyuridine'
[patent_app_type] => 1
[patent_app_number] => 9/301456
[patent_app_country] => US
[patent_app_date] => 1999-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5674
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/312/06312955.pdf
[firstpage_image] =>[orig_patent_app_number] => 301456
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/301456 | Streptococcus gordonii strains resistant to fluorodeoxyuridine | Apr 28, 1999 | Issued |
Array
(
[id] => 1460555
[patent_doc_number] => 06392015
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-21
[patent_title] => 'Method of identifying modulators of HIV-1 Vpu and Gag interaction with U binding protein (Ubp)'
[patent_app_type] => B1
[patent_app_number] => 09/301978
[patent_app_country] => US
[patent_app_date] => 1999-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 13112
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/392/06392015.pdf
[firstpage_image] =>[orig_patent_app_number] => 09301978
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/301978 | Method of identifying modulators of HIV-1 Vpu and Gag interaction with U binding protein (Ubp) | Apr 28, 1999 | Issued |
Array
(
[id] => 6032813
[patent_doc_number] => 20020019017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'METHOD AND KIT FOR OBTAINING FLUIDS AND CELLULAR MATERIAL FROM BREAST DUCTS'
[patent_app_type] => new
[patent_app_number] => 09/301058
[patent_app_country] => US
[patent_app_date] => 1999-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11313
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019017.pdf
[firstpage_image] =>[orig_patent_app_number] => 09301058
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/301058 | Methods using pressure to obtain fluids and cellular material from breast ducts | Apr 27, 1999 | Issued |
| 09/297225 | AAV-DNA HELPER VIRUS SEQUENCES | Apr 22, 1999 | Abandoned |
Array
(
[id] => 6674162
[patent_doc_number] => 20030059765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'COMPOSITIONS AND METHODS FOR PROVIDING A PROTEIN TO A VIRION'
[patent_app_type] => new
[patent_app_number] => 09/281495
[patent_app_country] => US
[patent_app_date] => 1999-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16771
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20030059765.pdf
[firstpage_image] =>[orig_patent_app_number] => 09281495
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/281495 | Compositions and methods for providing a protein to a virion | Mar 29, 1999 | Issued |
Array
(
[id] => 1476680
[patent_doc_number] => 06451304
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Method for retrovirus vector production by separated gag and pol expression'
[patent_app_type] => B1
[patent_app_number] => 09/265013
[patent_app_country] => US
[patent_app_date] => 1999-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 4824
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451304.pdf
[firstpage_image] =>[orig_patent_app_number] => 09265013
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/265013 | Method for retrovirus vector production by separated gag and pol expression | Mar 8, 1999 | Issued |
| 09/260430 | METHODS OF SUPPRESSING MICROGLIAL ACTIVATION | Feb 28, 1999 | Abandoned |
Array
(
[id] => 1338912
[patent_doc_number] => 06593457
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-15
[patent_title] => 'Lymphocyte-derived antimicrobial protein (LDAP) and methods of isolating and producing and using the protein'
[patent_app_type] => B1
[patent_app_number] => 09/254064
[patent_app_country] => US
[patent_app_date] => 1999-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5034
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/593/06593457.pdf
[firstpage_image] =>[orig_patent_app_number] => 09254064
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254064 | Lymphocyte-derived antimicrobial protein (LDAP) and methods of isolating and producing and using the protein | Feb 25, 1999 | Issued |
Array
(
[id] => 4282073
[patent_doc_number] => 06267966
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Vaccine production of the Bacillus anthracis protective antigen'
[patent_app_type] => 1
[patent_app_number] => 9/242846
[patent_app_country] => US
[patent_app_date] => 1999-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 4172
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/267/06267966.pdf
[firstpage_image] =>[orig_patent_app_number] => 242846
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/242846 | Vaccine production of the Bacillus anthracis protective antigen | Feb 24, 1999 | Issued |
Array
(
[id] => 1439948
[patent_doc_number] => 06495376
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-17
[patent_title] => 'Methods and compositions for regulating protein-protein interactions'
[patent_app_type] => B1
[patent_app_number] => 09/252404
[patent_app_country] => US
[patent_app_date] => 1999-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 21574
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/495/06495376.pdf
[firstpage_image] =>[orig_patent_app_number] => 09252404
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/252404 | Methods and compositions for regulating protein-protein interactions | Feb 17, 1999 | Issued |
| 09/246787 | FLUORESCENCE POLARIZATION METHOD FOR DETERMINING PROTEASE ACTIVITY | Feb 7, 1999 | Abandoned |